玻璃体视网膜手术设备市场机会、成长动力、产业趋势分析与预测 2025 - 2034

2024 年全球玻璃体视网膜手术设备市场价值为 17 亿美元，预计 2025 年至 2034 年的复合年增长率为 3.4%。这一增长主要得益于视网膜疾病发病率的上升，包括老年性黄斑部病变、糖尿病视网膜病变和视网膜剥离，随着全球人口老化，这些疾病变得越来越常见。此外，人们对微创手术的日益偏好推动了对尖端玻璃体视网膜设备的需求，因为与传统手术方法相比，这些手术往往能提供更快的恢復时间并减少患者的不适。门诊手术数量的不断增长也是这一趋势的关键因素，因为患者和医疗保健提供者越来越青睐具有成本效益、快速的手术，以避免长期住院。

政府和私营部门旨在提高人们的认识和改善视网膜疾病治疗可近性的倡议极大地促进了该市场的扩张。以早期诊断为重点的公共卫生运动以及及时介入的重要性的教育，正在帮助更多人了解这些先进外科治疗的必要性。此外，许多已开发国家提供的医疗保险和报销选项减少了财务障碍，使更多患者能够选择这些必要的手术。因此，认知度和可负担性在推动玻璃体视网膜手术设备的采用方面发挥关键作用。

市场多种多样，各种产品促进其成长。主要部分包括玻璃体切除术探头、玻璃体视网膜包、玻璃体切除术机器、照明设备、光凝固雷射和其他相关产品。其中，玻璃体视网膜包在 2024 年的收入为 6.021 亿美元，成为一个重要的市场区隔。这些包因其便利性而受到高度重视，因为它们包含预先组装的、消毒的仪器和消耗品，无需单独采购和消毒。这不仅节省了时间，还提高了医疗保健提供者的营运效率，降低了医院和诊所的准备成本。

在外科手术方面，后玻璃体视网膜手术领域可望大幅成长。预计到 2034 年该领域市场规模将达到 19 亿美元，主要得益于高速玻璃体切除机的进步、增强的术中成像以及更小、更精确的仪器的开发。这些创新提高了后段手术的效率和安全性，使其成为外科医生和患者更有吸引力的选择。

在美国，玻璃体视网膜手术设备市场规模在 2024 年达到 6.595 亿美元，预计到 2034 年将以 2.7% 的复合年增长率成长。这一增长得益于先进成像技术的日益普及，例如光学相干断层扫描 (OCT) 和即时视网膜成像，这些技术为外科医生在手术过程中提供了无与伦比的精确度。随着公众对视网膜疾病认识的提高和诊断工具的改进，越来越多的患者寻求透过手术来保留或恢復视力，进一步推动了对这些专用设备的需求。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 老年人口基数不断增加
    • 眼部疾病盛行率上升
    • 政府采取措施并投入资金改善视力保健
    • 玻璃体视网膜手术设备相关重大进展
  • 产业陷阱与挑战
    • 设备成本高
    • 报销情况的不确定性
• 成长潜力分析
• 监管格局
• 技术格局
• 差距分析
• 波特的分析
• PESTEL 分析
• 未来市场趋势
• 报销场景

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第 5 章：市场估计与预测：按产品，2021 年至 2034 年

• 主要趋势
• 玻璃体视网膜包
• 光凝雷射
• 玻璃体切除机
• 玻璃体切除术探头
• 照明设备
• 其他产品

第 6 章：市场估计与预测：依手术类型，2021 – 2034 年

• 主要趋势
• 后玻璃体视网膜手术
• 前部玻璃体视网膜手术

第 7 章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 糖尿病视网膜病变
• 视网膜剥离
• 黄斑部病变
• 其他应用

第 8 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 眼科诊所
• 门诊手术中心
• 其他最终用途

第 9 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• Alcon
• Bausch + Lomb
• BVI
• Carl Zeiss Meditec
• CooperVision
• Designs for Vision
• HOYA Surgical Optics
• MedOne
• OCULUS
• Oertli
• Peregrine Surgical
• STAAR SURGICAL

The Global Vitreoretinal Surgery Devices Market, valued at USD 1.7 billion in 2024, is set to experience a CAGR of 3.4% from 2025 to 2034. This growth is largely driven by the rising prevalence of retinal diseases, including age-related macular degeneration, diabetic retinopathy, and retinal detachment, which are becoming more common as populations age worldwide. Additionally, the increasing preference for minimally invasive surgical options is pushing the demand for cutting-edge vitreoretinal devices, as these procedures tend to offer faster recovery times and reduced patient discomfort compared to traditional surgical methods. The growing number of outpatient surgeries is also a key factor in this trend, as patients and healthcare providers increasingly favor cost-effective, quick procedures that avoid long hospital stays.

Government and private sector initiatives aimed at raising awareness and improving accessibility to retinal disease treatments are significantly contributing to the expansion of this market. Public health campaigns focused on early diagnosis, along with education about the importance of timely intervention, are helping more people understand the need for these advanced surgical treatments. Moreover, the availability of healthcare coverage and reimbursement options in many developed countries is reducing financial barriers, allowing more patients to opt for these necessary surgeries. As a result, both awareness and affordability are playing pivotal roles in driving the adoption of vitreoretinal surgery devices.

The market is diverse, with a range of products contributing to its growth. Key segments include vitrectomy probes, vitreoretinal packs, vitrectomy machines, illumination devices, photocoagulation lasers, and other related products. Among these, vitreoretinal packs generated USD 602.1 million in 2024, making them a significant segment. These packs are highly valued for their convenience, as they contain pre-assembled, sterilized instruments and consumables, eliminating the need for separate procurement and sterilization. This not only saves time but also enhances operational efficiency for healthcare providers, reducing preparation costs for hospitals and clinics.

In terms of surgical procedures, the posterior vitreoretinal surgery segment is poised for substantial growth. Expected to reach USD 1.9 billion by 2034, this segment is driven by advancements in high-speed vitrectomy machines, enhanced intraoperative imaging, and the development of smaller, more precise instruments. These innovations have improved the efficiency and safety of posterior segment surgeries, making them a more appealing option for surgeons and patients alike.

In the U.S., the vitreoretinal surgery devices market reached USD 659.5 million in 2024 and is projected to grow at a CAGR of 2.7% through 2034. This growth is fueled by the increasing adoption of advanced imaging technologies, such as optical coherence tomography (OCT) and real-time retinal imaging, which offer surgeons unparalleled precision during procedures. As public awareness of retinal diseases increases and diagnostic tools improve, more patients are seeking surgical options to preserve or restore their vision, further driving demand for these specialized devices.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing geriatric population base
    • 3.2.1.2 Rising prevalence of eye-related diseases
    • 3.2.1.3 Government initiatives and funding to improve vision care
    • 3.2.1.4 Significant advancements related to vitreoretinal surgery devices
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of devices
    • 3.2.2.2 Uncertainty in reimbursement scenario
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Gap analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Reimbursement scenario

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Vitreoretinal packs
• 5.3 Photocoagulation lasers
• 5.4 Vitrectomy machines
• 5.5 Vitrectomy probes
• 5.6 Illumination devices
• 5.7 Other products

Chapter 6 Market Estimates and Forecast, By Surgery Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Posterior vitreoretinal surgery
• 6.3 Anterior vitreoretinal surgery

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Diabetic retinopathy
• 7.3 Retinal detachment
• 7.4 Macular degeneration
• 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ophthalmic clinics
• 8.4 Ambulatory surgery centers
• 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Alcon
• 10.2 Bausch + Lomb
• 10.3 BVI
• 10.4 Carl Zeiss Meditec
• 10.5 CooperVision
• 10.6 Designs for Vision
• 10.7 HOYA Surgical Optics
• 10.8 MedOne
• 10.9 OCULUS
• 10.10 Oertli
• 10.11 Peregrine Surgical
• 10.12 STAAR SURGICAL